1 / 31

Overview Mina Goldiak, MSc

International Technological and Industrial R&D Cooperation. Overview Mina Goldiak, MSc. OCS - The Office of the Chief Scientist of the Ministry of Economy is responsible for implementing government policy regarding support and encouragement of industrial research and development.

lucus
Download Presentation

Overview Mina Goldiak, MSc

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. InternationalTechnological and Industrial R&D Cooperation OverviewMina Goldiak, MSc

  2. OCS- The Office of the Chief Scientist of theMinistry of Economy is responsible for implementing government policy regarding support and encouragement of industrial research and development.

  3. “Heavier-than-air flying machines are impossible"  Lord Kelvin, 1895

  4. “640 K Ought to be enough for anybody " Bill Gates, 1981

  5. Ministry of Economy Office of the Chief Scientist Some Facts about Israel: • Population ~ 8 million • Area 22,000 sq km • Households ~ 1.9 million • Average Household ~ 3.6 persons • GDP $B140.6 • GDP/Capita $24,600 • Inflation 3% • Unemployment <7% • Growth Rate 2.7-3.5%

  6. Expenditure on Civilian R&D as a percent of the GDP in Israel and in OECD Countries 5 4 . 6 4 3 . 6 3 . 2 3 . 0 2 . 7 3 2 . 4 2 . 4 2 . 3 2 . 2 2 . 1 2 . 0 2 . 0 1 . 9 1 . 8 2 1 . 6 1 . 6 1 . 6 1 . 4 1 . 4 1 . 3 1 . 1 1 . 0 0 . 9 0 . 8 0 . 7 0 . 7 1 0 UK Italy USA Israel Spain Korea Japan Ireland France Finland Iceland Austria Greece Belgium Canada Norway Portugal Australia Sweden Germany Denmark Switzerland New Zeland Netherlands Czech Republic Slovak Republic Source: Ministry of finance If you lie on the ground, you cannot fall…

  7. Scientists & Technicians per 10,000 Workers

  8. Israel’sCompetitiveEdge Business Expenditure On R&D ( % GDP) 1st Total Expenditure On R&D ( % GDP) 1st Entrepreneurship 2nd Skilled Labor 4th Venture Capital 5th Flexibility And Adaptability 6th Source: IMD World Competitiveness Yearbook 2012

  9. Ministry of Economy Office of the Chief Scientist Patents (2008) • Israel ranked #1 in Medical Device patents per capita • Israel ranked #5 in number of patents per capita Source: The United States Patent and Trademark Office (June 2008)

  10. Innovation = Economic Growth “If you want real growth, you have to have new technologies” Source: Business Week

  11. OCS Grants by Technological Sectors 2012

  12. No. Of Applications: ~ 2000 Projects Requested Budget: ~ 6.7 Billion NIS Total Grants:~ 1.57 Billion NIS Ministry of Industry, Trade and Labor Office of the Chief Scientist OCS 2012 Some Figures

  13. ISERD (Europe FP) Government Support Programs Pre-Seed Generic R&D Competitive R&D Cooperative R&D Tnufa Magnet Industrial R&D TechnologicalIncubators Magneton National Seed Fund Nofar Long-Range R&D Bi-national Funds Bi-national Agreements International Galileo EUREKA Global Enterprises R&D Cooperation Applied Academic Research Basic R&D Market Proximity

  14. Ministry of Industry, Trade and Labor Office of the Chief Scientist Technological Incubators Pre-Seed & Seed R&D • 2012 Budget – NIS 180 M • A framework for nascent companies to develop their innovative technological ideas into start-ups that can attract private investors • Suitable facilities for R&D activity & administrative and logistic support to projects 24 Incubators 2 Industrial Incubators 1 Biotechnology incubator 8-10 projects in each Grants- up to 85%

  15. Ministry of Industry, Trade and Labor Office of the Chief Scientist Magnet Generic R&D • 2012 Budget – NIS 181 M • Supports consortia of industrial companies and academic institutions. • Target: jointly develop generic, pre competitive technologies or dissemination existing new technologies. • The technology cannot be acquired from commercial sources at competitive prices • Grants of up to 66% - no royalty repayments • Magneton, Nofar, Nataf, Katamon

  16. Ministry of Industry, Trade and Labor Office of the Chief Scientist R&D Fund Competitive R&D • 2012 Grants – NIS 1070 M, ~2000 requests per year • Supports competitive R&D of mature companies (SME’s as well as big companies) • Target: establish and develop substantial industrial R&D infrastructure • Grants between 30-50% of R&D plan, royalties payments - obligatory upon success • Acquisition and transfer of knowledge due to special approvals • Budgetary platform for all bilateral parallel agreements

  17. ISERD (Europe FP) Government Support Programs Pre-Seed Generic R&D Competitive R&D Cooperative R&D Tnufa Magnet Industrial R&D TechnologicalIncubators Magneton National Seed Fund Nofar Long-Range R&D Bi-national Funds Bi-national Agreements International Galileo EUREKA Global Enterprises R&D Cooperation Applied Academic Research Basic R&D Market Proximity

  18. BIRDF-with U.S.A. USISTC/F SIIRD-with Singapore CIIRDF - with Canada KORIL-RDF - With S. Korea Ministry of Economy Office of the Chief Scientist International Cooperation Foundations:

  19. Ministry ofEconomy)Office of theChief Scientist MATIMOP encourages participation in the many international programs for bi–lateral and multi-lateral cooperation in industrial R&D , signed and funded by the Office of the Chief Scientist (OCS) of the Ministry of Economy.

  20. Bi-National Support Agreements Europe FranceRussiaItalyGermanyGreeceDenmarkHungaryTurkeyPortugalFinlandSweden Czech RepublicNetherlands Lithuania Slovenia Cyprus Bulgaria Trento (Italy) North America New YorkMarylandVirginiaWisconsinColorado Massachusetts Oregon Ontario Asia India China Jiangsu Province Shanghai Shenzhen Shandong Province South America ArgentinaUruguay Brazil Australia Victoria

  21. VISTECH: Victoria-Israel Science & Tech R&D Fund In Israel In Victoria • The Victoria-Israel Science and Technology R&D Fund (VISTECH)promotes, facilitates and supports cooperative science and technology research and development (R&D) projects between Israeli and Victorian Companies • Program is based on an MOU between Israel’s Ministry of Economy (formerly Ministry of Industry, Trade and Labor) and the Government of Victoria, signed in February 2005 • Program launched in December 2005 with first Call for Proposals • Implemented through: The Department of State Development, Business and Innovation at Government of Victoria • MATIMOP, through the Office of the Chief Scientist (OCS) of the Ministry of Economy

  22. VISTECH: Victoria-Israel Science & Tech R&D Fund Funding in Victoria Funding in Israel Next Call For Proposals: Sept/Oct 2013 • VISTECH Activities: • Partner-matching - Matching companies in one state seeking a partner in the other • Support Activities - B2B events and activities promoting and marketing the benefits of joint, market oriented Victorian-Israeli R&D collaboration • Funding - Supporting joint R&D projects by contributing up to 50% of the joint eligible R&D costs, based on local funding rules: • Up to 50% of the approved R&D expenses • Soft loan/conditional grant • Funding provided through the Office of the Chief Scientist’s R&D Fund • Details of funding to be announced • Up to 50% of the approved R&D expenses

  23. VISTECH: Victoria-Israel Science & Tech R&D Fund • FOR MORE INFORMATION:

  24. VISITS - Victoria-Israel Science Innovation and Technology Scheme • The Victoria-Israel Science Innovation and Technology Scheme (VISITS) launched in May 2013 by Gov. of Victoria (Dept. of State Development, Business and Innovation) to support Victorian-Israeli cooperation • VISITS builds on the outcomes of the VISTECH program (running since 2005) - Following a review of the program, additional support streams for Australian companies have been introduced to form the VISITS program: • VISTRADE: Trade Missions - VISTRADE supports the organization and management of Australian trade missions to Israel, run by the Australia-Israel Chamber of Commerce (AICC) • VISTRIP: Victoria-Israel Trade and International Partnering - VISTRIP provides grant assistance for eligible Victorian organizations to attend recognized trade missions, conferences and meetings in Israel • VISFPC : Victoria-Israel Feasibility and Proof of Concept - VISFPC provides assistance of up to $50,000 to Victorian organizations to collaborate on feasibility and /or proof of concept studies with Israeli organizations (not open for applications yet) • VISTECH: Victoria-Israel Science and Technology R&D Fund – VISTECH supports collaborative R&D projects by Victorian and Israeli organizations whose technologies have commercial applications (not open for applications yet) Support ONLY to Victorian Entities Support to Both Victorian & Israeli Entities

  25. International Cooperation Models Multi-National Agreements Ministry of Economy Office of the Chief Scientist The European FP7 EUREKA

  26. European inter-governmental framework for 40 R&D national programs directed to support industrial innovation • Approves yearly 300 industrial R&D projects with total budget of €1.5 B • Israeli companies participate in 40 cooperation projects a year – more than 10% of total activity • Israel was the chairmanship for 2010-2011 Ministry of Economy Office of the Chief Scientist EUREKA Program

  27. Integrated Model – Total Returns to the Economy

  28. Global Enterprise R&D Collaboration • 24 Multinational from all over the world: Abbott Alcatel-Lucent Arkema B. Braun BT Coca-Cola DuPont GE HP IBM Bombardier Transportation Deutsche Telekom Infosys Intel Life Technologies Merck Microsoft Novozymes Oracle Philips Posco Procter & Gamble Renault Telecom Italia $6M granted to >80 Joint Projects (since launching the program in 2005)

  29. Argo Medical invented the external wearable skeleton enabling the walking of paraplegic patients. • TNUFA grantee • Technological Incubator graduate • BIRD joint project with Allied Orthotics & Prosthetics

  30. “It’s not the strongest of the species that survives, nor the most intelligent; it is the one that is most adaptable to change” Charles Darwin Charles Darwin

  31. For More Detailed Information Mina Goldiak, MscDeputy Chief Scientist International R&D Relations and Cooperation 29 Hamered Street Tel Aviv 61500, Israel Tel: +972 (3) 511 81 75 Fax: +972 (3) 517 76 55Email:minag@matimop.org.il 

More Related